Augmenting Balance in Individuals With Cerebellar Ataxias
NCT ID: NCT02887703
Last Updated: 2018-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2016-09-30
2018-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Training on Brain Volume in Ataxia
NCT04837027
Wearable Gait Sensors
NCT06628934
Ataxia and Exercise Disease Using MRI and Gait Analysis
NCT03701776
Aerobic Exercise, Balance Training, and Ataxia
NCT03745248
Vibrotactile Balance Belt Effect on Improving Gait
NCT07253532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sensory Augmentation Group 1
Each subject in Group 1 will undergo 6 weeks of balance training with sensory augmentation followed by 6 weeks of balance training without sensory augmentation.
Sensory Augmentation
Sensory augmentation is a technique of augmenting or replacing compromised sensory information. In the context of sensory-based balance impairments, a sensory augmentation device provides cues of body motion that supplement an individual's remaining intact sensory systems.
Sensory Augmentation Group 2
Each subject in Group 2 will undergo 6 weeks of balance training without sensory augmentation followed by 6 weeks of balance training with sensory augmentation.
Sensory Augmentation
Sensory augmentation is a technique of augmenting or replacing compromised sensory information. In the context of sensory-based balance impairments, a sensory augmentation device provides cues of body motion that supplement an individual's remaining intact sensory systems.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sensory Augmentation
Sensory augmentation is a technique of augmenting or replacing compromised sensory information. In the context of sensory-based balance impairments, a sensory augmentation device provides cues of body motion that supplement an individual's remaining intact sensory systems.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are able to read and comprehend English
* Have been diagnosed with either an inherited or sporadic degenerative cerebellar or sensory ataxia
* Are able to stand for at least 30 seconds with no support
* Must be willing and able to comply with study schedule
* Must have wireless internet (WiFi) enabled in their home
* Must be able to perform the home based exercises safely (as assessed by clinical research staff)
Exclusion Criteria
* Have been diagnosed with arthritis or other musculoskeletal disorder affecting joints, muscles, ligaments and/or nerves that affects the way subject moves
* Have a history of fainting
* Have a severe vision or hearing impairment that is not corrected by glasses or hearing aids
* Have sustained a fall in the last six months that resulted in hospitalization or serious injury
* Have corrected vision worse than 20/70 (considered threshold for moderate visual impairment)
* Are unable to feel the vibrotactile feedback on their torso through the standard t-shirt provided by the study team
* Have ankle dorsi-flexor/plantar-flexor weakness as demonstrated \< 4/5 on manual muscle test
* Have limited ankle range of motion demonstrated by inability to dorsiflex to neutral with the knee extended
* Report lower extremity fracture/sprain in the past six months or more than one lower extremity total joint replacement
* Are medically unstable (e.g. chest pain upon exertion, dyspnea, infection)
* Have a history of any other neurological disease besides ataxia that might affect balance (e.g. cerebral vascular accident, Parkinson's disease, MS, ataxia)
* Have a body mass index (BMI) over 30 kg/m2, computed from subject height and weight
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kathleen Sienko
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kathleen Sienko
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathleen H Sienko, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Mechanical Engineering
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Mechanical Engineering, University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00116756
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.